POH 0.00% 0.0¢ progress 2023-2 trust

Ann: Phosphagenics Arbitration Award Issued, page-224

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,498 Posts.
    lightbulb Created with Sketch. 310
    @Secondopinion


    Thx kind words and do trust I present in a balanced and fairly unbiased manner with supportive evidence to my statements & conclusions. 


    In fairness to @playez I can see what they are saying however I don't believe it is as absolute and categorical as they make out. 


    Is it stacked against POH now - yes. 


    Does it mean dead here & now - no. 


    Have they got work cut out - yes. 


    I agree as u say, some supporting evidence from playez re their statements would be appreciated however there is nothing that says they have to. 


    Is TPGS a direct competitor in the "same" DDS right now - not that I can see and happy to be corrected if so. 


    Will TPGS become a direct competitor in the future - possibly if they move into that DDS. 


    That is when POH should provide direct comparison studies as TPGS would then be a competitor but not yet. 


    Seeing playez has now shifted part of the discussion around supply chain, does TPGS have that advantage & scale - absolutely as it's been around that long in oral DDS so to be expected. 


    Does that mean POH couldn't secure production & supply chain if required - no. 


    Must first have a product requirement to that level to proceed down that path and obviously POHs focus atm still is product dev and ultimately commercialisation first then supply chain in parallel. 


    I still believe TPGS is not developed as yet for transdermal / injectable however if it does become available then yes, existing infrastructure will assist it. 


    But does that also mean these producers / suppliers couldn't also assist with TPM? 


    Does the mkt say there can be a monopoly of only one transdermal / injectable compound support? 


    Even from isochem pdf it clearly states that the DDS discussed is merely being investigated at this time (pg 2).


    https://www.google.com.au/url?sa=t&source=web&rct=j&url=https://pmcisochem.fr/sites/default/files/documents/ISOCHEM%2520TPGS%25202015%252008.pdf&ved=2ahUKEwi36Lq1mt_eAhUHr48KHc4-DFoQFjACegQICRAB&usg=AOvVaw0i5szO5YQ_vP7zoOaRps-g&cshid=1542587606594


    While here and couldn't see mention of it on a thread search (maybe in an Ann somewhere but not checked?), anyone know of Lambada and how they fit? 


    http://www.lambdacanada-cro.com/targeted-penetration-matrix-tpm-innovative-transdermal-delivery-system/


    Cheers FMF

    Last edited by FullMoonFever: 19/11/18
 
watchlist Created with Sketch. Add POH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.